Our experience in the treatment of metastatic lesions of the brain and spine in primary pochechnokletochnyj cancer

• الحاوية / القاعدة: Кубанский научный медицинский вестник
• المؤلفون الرئيسيون: I. V. Balyazin-Parfenov, E. E. Rostorguev, D. P. Atmachidi, E. A. Fedosov, S. E. Kaviccki, A. N. Shevchenko, O. V. Tarnopolskaya
• التنسيق: مقال
• اللغة: الروسية
• منشور في: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2015-08-01
• الموضوعات: церебральные метастазы; метастазы светлоклеточного рака почки; рак почки; таргетная терапия; brain metastasis; clear cell carcinoma kidney cancer; kidney cancer; targeted therapy
• الوصول للمادة أونلاين: https://ksma.elpub.ru/jour/article/view/354
• تدمد: 1608-6228; 2541-9544

Metastatic brain and spine when kidney cancer is one of the leading places. Surgical treatment with subsequent targeted therapy did not significantly improve the lifetime and the duration of DFS in this group of patients. A comparative study of simultaneous operated patients clear cell carcinoma kidney cancer with subsequent targeted therapy Nexavar and patients operated two-stage, with removal of the primary lesion, then - metastatic and subsequent targeted therapy has shown the feasibility of simultaneous operations. The life expectancy of patients, simultaneous operated above. However, a significant increase is not marked, that makes us keep looking for new ways to solve the problem